INDmoney
Lipocine Inc Stock Performance
as on February 7, 2026 at 7:57 am IST
Day's Low
Day's High
$7.95$8.91
7.77%
Downside
3.36%
Upside
52 Week's Low
52 Week's High
$2.52$12.3770.77%
Downside
43.50%
Upside
Lipocine Inc share price movements today
- Previous Close
- $7.72
- Open
- $7.95
- Volume
- 381.2K
- Day's Low - High
- $7.95 - $8.91
- 52 Week Low - High
- $2.52 - $12.37
Lipocine Inc Historical Returns
- 1 Month Return
- + 12.9 %
- 3 Month Return
- + 234.25 %
- 1 Year Return
- + 142.57 %
- 3 Year Return
- -9.18 %
- 5 Year Return
- -73 %
Lipocine Inc Stock Fundamentals & Key Indicators
Check Lipocine Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$59.5M
EPS (TTM)
-1.965
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-6.2M
Revenue (TTM)
4.3M
Profit Margin
-126.66%
Return On Equity TTM
-32.92%
Lipocine Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lipocine Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $59.5M | -73% | NA | -126.66% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
Stock Returns calculator for Lipocine Inc Stock including INR - Dollar returns
The Lipocine Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lipocine Inc investment value today
Current value as on today
₹2,49,595
Returns
₹1,49,595
(+149.59%)
Returns from Lipocine Inc Stock
₹1,46,286 (+146.29%)
Dollar Returns*
₹3,309 (+3.31%)
Analyst Recommendation on Lipocine Inc Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Lipocine Inc. Average target price of $10.88
Lipocine Inc Share Price Target
Get share price movements and forecasts by analysts on Lipocine Inc.
What analysts predicted
20.77%UPSIDE
Target Price
$10.88
Current Price
$8.62
Analyzed by
7 Analysts
Target
$10.88
Lipocine Inc target price $10.88, a slight upside of 20.77% compared to current price of $8.62. According to 7 analysts rating.
Lipocine Inc Stock’s Investor Sentiment and Interest
Search interest for Lipocine Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Lipocine Inc Quarterly Profit & Loss
All numbers in Millions USD
Lipocine Inc Annual Profit & Loss
All numbers in Millions USD
Lipocine Inc Quarterly Cash Flow
All numbers in Millions USD
Lipocine Inc Annual Cash Flow
All numbers in Millions USD
Insights on Lipocine Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, LPCN has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, LPCN stock has moved up by 234.3%
NO EFFECTAgainst Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.1% return, outperforming this stock by 51.3%
About Lipocine Inc
| Organisation | Lipocine Inc |
| Headquarters | 675 Arapeen Drive, Salt Lake City, UT, United States, 84108 |
| Industry | Health Technology |
| CEO | Dr. Mahesh V. Patel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Lipocine Inc
Name | Title |
|---|---|
Ms. Krista Fogarty | Principal Accounting Officer & Corporate Controller |
Dr. Nachiappan Chidambaram Ph.D. | Senior Vice President of Research & Development |
Mr. Logan Morse | Vice President of Sales, Marketing & Operations |
Dr. Anthony DelConte M. D., M.D. | Chief Medical Director |
Dr. Mahesh V. Patel Ph.D. | Co-Founder, Interim Principal Financial Officer, Director, President & CEO |
FAQs
What is Lipocine Inc share price today?
Lipocine Inc share price today is $8.62 as on at the close of the market. Lipocine Inc share today touched a day high of $8.91 and a low of $7.95.
What is the 52 week high and 52 week low for Lipocine Inc share?
Lipocine Inc share touched a 52 week high of $12.37 on and a 52 week low of $2.52 on . Lipocine Inc stock price today i.e. is closed at $8.62,which is 30.32% down from its 52 week high and 242.06% up from its 52 week low.
What is Lipocine Inc's market capitalisation today?
Lipocine Inc market capitalisation is $0.00T as on .
How to invest in Lipocine Inc Stock (LPCN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Lipocine Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lipocine Inc Shares that will get you 0.1740 shares as per Lipocine Inc share price of $8.62 per share as on February 7, 2026 at 2:27 am IST.
What is the minimum amount required to buy Lipocine Inc Stock (LPCN) from India?
Indian investors can start investing in Lipocine Inc (LPCN) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Lipocine Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lipocine Inc share’s latest price of $8.62 as on February 7, 2026 at 2:27 am IST, you will get 1.1601 shares of Lipocine Inc. Learn more about
fractional shares .
What are the returns that Lipocine Inc has given to Indian investors in the last 5 years?
Lipocine Inc stock has given -73% share price returns and 23.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?